178 Participants NeededMy employer runs this trial

Avance Nerve Graft for Peripheral Nerve Injury

(Nerve-RESTORE℠ Trial)

SA
HN
Overseen ByHayley Nicolosi
Age: 18+
Sex: Any
Trial Phase: Phase 4
Sponsor: Axogen Corporation
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This is a multicenter, 1:1 randomized, prospective, comparative study in participants requiring reconstruction of a mixed or motor nerve in the upper extremity. This study will consist of a screening visit, an operative visit, and 9 post-operative follow-up visits at Week 4, and Months 3, 6, 9, 12, 15, 18, 21, and 24.

Who Is on the Research Team?

RG

R. Glenn Gaston, MD

Principal Investigator

OrthoCarolina Research Institute, Inc.

Are You a Good Fit for This Trial?

This trial is for people who need surgery to repair a mixed or motor nerve injury in their arm. Participants must be able to attend regular follow-up visits after surgery. People with certain health conditions or factors that could affect healing may not be eligible.

Inclusion Criteria

Provide documented IRB/IEC-approved informed consent prior to initiation of any study procedures
I need nerve repair surgery in my arm using a nerve graft for a fully cut nerve.
All my eligible nerve repairs were done with the same type of graft.
See 7 more

Exclusion Criteria

My nerve injury is not completely severed.
I have significant soft tissue damage that affects my recovery.
I have a nerve injury where the nerve has been torn or pulled apart.
See 16 more

What Are the Treatments Tested in This Trial?

Interventions

  • Avance Nerve Graft
  • Sural nerve autograft

Trial Overview

The study compares two ways of repairing damaged nerves in the arm: using an Avance Nerve Graft (a processed donor nerve) versus a sural nerve autograft (using the patient's own nerve). Patients are randomly assigned to one group and followed for up to 2 years.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Avance Nerve GraftExperimental Treatment1 Intervention
Group II: Sural nerve autograftActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Axogen Corporation

Lead Sponsor

Trials
11
Recruited
5,600+